Skip to main content
NCBI home page
Springer logoLink to Springer
. 2022 Oct 17;41(12):3925. doi: 10.1007/s10067-022-06412-8

Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

Yael Pri-Paz Basson 1,2, Oshrat E Tayer-Shifman 1,2, Rawand Naser 1, Shelly Tartakover Matalon 2,3, Oded Kimhi 4, Raz Gepstein 5, Tamar Halperin 6, Tomer Ziv-Baran 2, Amit Ziv 7, Roma Parikh 8, Shaye Kivity 1,2,✉, Yair Levy 2,9
PMCID: PMC9828834  PMID: 36251175

Correction to: Clinical Rheumatology

https://doi.org/10.1007/s10067-022-06348-z

In the original published version of the above article, the co-author‘s name was incorrectly presented as "Oshrat E. Tayar‑Shifman". This is now corrected as "Oshrat E. Tayer-Shifman" and cited correctly as, "Tayer-Shifman, O.E.".

The original article has been corrected.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Clinical Rheumatology are provided here courtesy of Springer

RESOURCES